Experts forecast Trump administration could usher in new era of mergers and acquisitions among drugmakers
Deals in the pharmaceutical industry have sunk to their lowest level in almost a decade, as the world’s biggest drugmakers shy away from big bets on commercially ready medicines in favour of earlier-stage drug developers. By late November, pharma groups such as Eli Lilly, Novartis and Vertex Pharmaceuticals had completed a total of 558 deals globally, worth a combined value of $67.2bn, the lowest level for that stage of the year since 2016, according to London Stock Exchange data.
” Some bigger deals have been completed this year but none were instances in which a pharma group was buying a biotech to get hold of promising drugs. Novo Nordisk this year agreed to pay $11bn to acquire three manufacturing sites from Catalent in a three-way deal involving its parent company, while Sanofi handed control of its consumer drug division to private equity group Clayton Dubilier & Rice in a €16bn deal.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trump wins latest: Trump makes first major appointment; three states move to 'Trump-proof' lawsVladimir Putin has described Donald Trump as a 'bullied' and 'brave man' after his monumental political comeback. Meanwhile, three states, including America's most populous, are making moves to protect liberal policies from the next administration.
Read more »
Robert Kennedy Jr’s influence over Donald Trump sparks Big Pharma alarmVaccine sceptic expected to hold sway over health policy and top appointments
Read more »
Trump victory a blow to climate action, experts sayTrump's election will hit immediate efforts to tackle climate change, experts say - but the longer-term effect is less certain.
Read more »
How investors could profit from Donald Trump's victory, according to expertsLove him or loathe him, there may be opportunities to make money under Trump - here's how
Read more »
Public Health Experts Alarmed at Trump’s Pick of RFK Jr. to Lead HHSPublic health experts worry about the impact of Robert F. Kennedy Jr.'s nomination by Trump to lead the Department of Health and Human Services.
Read more »
UK and Europe can't support Ukraine alone when Trump returns, defence experts warnImminent arrival of Donald Trump means the focus of the Ukraine war has shifted
Read more »